A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
TE-ITP study: Compare the efficacy and safety of optimized rhTPO treatment versus Eltrombopag
treatment in previously treated primary immune thrombocytopenia patients.
Phase:
Phase 4
Details
Lead Sponsor:
Institute of Hematology & Blood Diseases Hospital
Collaborators:
Cangzhou Central Hospital Daqing Oil Field Hospital Henan Cancer Hospital North China University of Science and Technology Affiliated Hospital Second Affiliated Hospital of Guangzhou Medical University Second Hospital of Shanxi Medical University Shaanxi Provincial People's Hospital Shenyang Sunshine Pharmaceutical Co., LTD. Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University The Affiliated Hospital of Inner Mongolia Medical University The Second Affiliated Hospital of Dalian Medical University The Second Affiliated Hospital of Harbin Medical University The Second Affiliated Hospital of Kunming Medical University The Second Hospital of Hebei Medical University Xijing Hospital Yuncheng Central Hospital